NCT02972918View on ClinicalTrials.gov

Preoperative levosimendán and Hip Fracture

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

September 30, 2018

Study Completion Date

April 30, 2019

Conditions
Ventricular Dysfunction, LeftHip Fracture
Interventions
DRUG

Levosimendan

24h preoperative infusion of levosimendan (0,1 mcg/Kg/min)

Trial Locations (1)

38320

Complejo Hospitalario Universitario de Canarias, San Cristóbal de La Laguna

All Listed Sponsors
collaborator

Orion Corporation, Orion Pharma

INDUSTRY

lead

Hospital Universitario de Canarias

OTHER

NCT02972918 - Preoperative levosimendán and Hip Fracture | Biotech Hunter | Biotech Hunter